Nonlinearity association between hyperuricemia and all-cause mortality in patients with chronic kidney disease – Scientific Reports

  • Dalbeth, N., Gosling, A. L., Gaffo, A. & Abhishek, A. Gout. Lancet (London England) 397(10287), 1843–1855 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Li, C., Hsieh, M. C. & Chang, S. J. Metabolic syndrome, diabetes, and hyperuricemia. Curr. Opin. Rheumatol. 25(2), 210–216 (2013).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Amiya, E. Link between hyperuricemia, renal dysfunction, and hypertension. J. Clin. Hypertens. (Greenwich) 23(12), 2078–2079 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Zhang, S. et al. Hyperuricemia and cardiovascular disease. Curr. Pharm. Des. 25(6), 700–709 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ramirez-Sandoval, J. C. & Madero, M. Treatment of hyperuricemia in chronic kidney disease. Contrib. Nephrol. 192, 135–146 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Butler, F., Alghubayshi, A., Roman, Y. The epidemiology and genetics of hyperuricemia and gout across major racial groups: A literature review and population genetics secondary database analysis. J. Personal. Med. 11(3) (2021).

  • Levey, A. S. et al. Chronic kidney disease as a global public health problem: Approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 72(3), 247–259 (2007).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Coresh, J. et al. Prevalence of chronic kidney disease in the United States. JAMA. 298(17), 2038–2047 (2007).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhang, L. et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet (London, England). 379(9818), 815–822 (2012).

    Article 
    PubMed 

    Google Scholar
     

  • Sturm, G., Kollerits, B., Neyer, U., Ritz, E. & Kronenberg, F. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp. Gerontol. 43(4), 347–352 (2008).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Madero, M. et al. Uric acid and long-term outcomes in CKD. Am. J. Kidney Dis. 53(5), 796–803 (2009).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dousdampanis, P., Trigka, K., Musso, C. G. & Fourtounas, C. Hyperuricemia and chronic kidney disease: An enigma yet to be solved. Renal Failure. 36(9), 1351–1359 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Giordano, C., Karasik, O., King-Morris, K. & Asmar, A. Uric acid as a marker of kidney disease: Review of the current literature. Dis. Mark. 2015, 382918 (2015).


    Google Scholar
     

  • Gul, A., Harford, A. & Zager, P. Mendelian randomization to establish the causality of uric acid with diabetic nephropathy in type 1 diabetics. Kidney Int. 91(5), 1005–1007 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zoccali, C. & Mallamaci, F. Uric acid in chronic kidney disease: the quest for causality continues. Nephrol. Dialysis Transplant. 33(2), 193–195 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Li, L. et al. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 15, 122 (2014).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Srivastava, A., Kaze, A. D., McMullan, C. J., Isakova, T. & Waikar, S. S. Uric acid and the risks of kidney failure and death in individuals with CKD. Am. J. Kidney Dis. 71(3), 362–370 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lee, C. L. & Tsai, S. F. Association between mortality and serum uric acid levels in non-diabetes-related chronic kidney disease: An analysis of the National Health and Nutrition Examination Survey, USA, 1999–2010. Sci. Rep. 10(1), 17585 (2020).

    Article 
    ADS 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tsai, C. W. et al. Uric acid predicts adverse outcomes in chronic kidney disease: a novel insight from trajectory analyses. Nephrol. Dial. Transplant. 33(2), 231–241 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Prezelin-Reydit, M. et al. Longitudinal uric acid has nonlinear association with kidney failure and mortality in chronic kidney disease. Sci. Rep. 13(1), 3952 (2023).

    Article 
    ADS 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Siu, Y. P., Leung, K. T., Tong, M. K. & Kwan, T. H. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am. J. Kidney Dis. 47(1), 51–59 (2006).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Goicoechea, M. et al. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Am. J. Kidney Dis. 65(4), 543–549 (2015).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sircar, D. et al. Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricemia: A 6-month, double-blind, randomized, placebo-controlled trial. Am. J. Kidney Dis. 66(6), 945–950 (2015).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Goicoechea, M. et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin. J. Am. Soc. Nephrol.: CJASN. 5(8), 1388–1393 (2010).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kim, C. S. et al. Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data. Kidney Res. Clin. Pract. 36(4), 368–376 (2017).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chini, L. S. N., Assis, L. I. S. & Lugon, J. R. Relationship between uric acid levels and risk of chronic kidney disease in a retrospective cohort of Brazilian workers. Braz. J. Med. Biol. Res. 50(9), e6048 (2017).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chonchol, M. et al. Relationship of uric acid with progression of kidney disease. Am. J. Kidney Dis. 50(2), 239–247 (2007).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sampson, A. L., Singer, R. F., Walters, G. D. Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease. Cochrane Database Syst Rev. 10(10):Cd009460 (2017).

  • Kibria, G. M. A. & Crispen, R. Prevalence and trends of chronic kidney disease and its risk factors among US adults: An analysis of NHANES 2003–18. Prev Med Rep. 20, 101193 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Otani, N. et al. Effects of uric acid on vascular endothelial function from bedside to bench. Hypertension Res. 41(11), 923–931 (2018).

    Article 

    Google Scholar
     

  • Wang, X. D. et al. Correlation between the elevated uric acid levels and circulating renin-angiotensin-aldosterone system activation in patients with atrial fibrillation. Cardiovasc. Diagn. Ther. 11(1), 50–55 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ponticelli, C., Podestà, M. A. & Moroni, G. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease. Kidney Int. 98(5), 1149–1159 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Badve, S. V. et al. Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med. 382(26), 2504–2513 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Doria, A. et al. Serum urate lowering with allopurinol and kidney function in type 1 diabetes. N Engl J Med. 382(26), 2493–2503 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Suliman, M. E. et al. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis. 48(5), 761–771 (2006).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Odden, M. C., Amadu, A. R., Smit, E., Lo, L. & Peralta, C. A. Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988–1994 and 1999–2002. Am. J. Kidney Dis. 64(4), 550–557 (2014).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • FitzGerald, J. D. et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care Res. 72(6), 744–760 (2020).

    Article 

    Google Scholar
     

  • CSo e. Guideline for the diagnosis and management of hyperuricemia and gout in China (2019). Chin. J. Endocrinol. Metab. 36(01), 1–13 (2020).

  • Wang, H., Zhang, H., Sun, L. & Guo, W. Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases. Am. J. Transl. Res. 10(9), 2749–2763 (2018).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kuwabara, M. et al. Hyperuricemia is an independent competing risk factor for atrial fibrillation. Int. J. Cardiol. 231, 137–142 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Wu, X. et al. Asymptomatic hyperuricemia and incident congestive heart failure in elderly patients without comorbidities. Nutr. Metab. Cardiovasc. Dis.: NMCD. 30(4), 666–673 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jayachandran, M. & Qu, S. Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence. Med. Res. Rev. 41(1), 616–629 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Li, M., Hou, W., Zhang, X., Hu, L. & Tang, Z. Hyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studies. Atherosclerosis. 232(2), 265–270 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar